Back
Veracyte Stock Predictions

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
57
VCYT
Veracyte
Last Price:
$28.48
Seasonality Move:
18.25%
7 Day Trial
ALL ACCESS PASS
$
7

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report hereVeracyte Stock Forecast
-
Over the next 52 weeks, Veracyte has on average historically risen by 29.4% based on the past 11 years of stock performance.
-
Veracyte has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
-
Is Veracyte Stock Undervalued?The current Veracyte [VCYT] share price is $29.31. The Score for VCYT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
VCYT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Veracyte Stock Go Up Next Year?
-
Over the next 52 weeks, Veracyte has on average historically risen by 29.4% based on the past 11 years of stock performance.
Veracyte Stock Rating
Buy
57
Veracyte (VCYT)
is a Buy
Is Veracyte overpriced?
-
Veracyte has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
Veracyte Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
veracyte.com
52-Week Data
52-Week High:
47.32
52-Week Low:
19.73
Prediction Charts
Market Cap:
2.3B
Price in USD:
29.31
Volume:
1.6M
Beta:
1.56
Technical Analysis
SMA50:
31.15
SMA100:
36.30
SMA200:
34.95
52-Wk Change:
30.27%
Stock Predictions
-
Is Veracyte stock public?Yes, Veracyte is a publicly traded company.
-
What is the Veracyte stock quote today?The Veracyte stock price is 29.31 USD today.
-
How to buy Veracyte stock online?You can buy Veracyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-24 | 31.56 | 32.14 | 32.17 | 31.50 |
Apr-25 | 32.00 | 32.23 | 32.36 | 31.71 |
Apr-28 | 32.38 | 31.67 | 32.85 | 30.99 |
Apr-29 | 31.60 | 31.38 | 31.90 | 31.10 |
Apr-30 | 30.66 | 30.50 | 31.38 | 30.16 |
May-1 | 30.64 | 29.71 | 30.71 | 29.30 |
May-2 | 30.13 | 30.35 | 30.84 | 29.92 |
May-5 | 30.48 | 31.32 | 31.60 | 30.45 |
May-6 | 30.67 | 30.56 | 31.06 | 30.03 |
May-7 | 30.76 | 30.84 | 30.99 | 29.56 |
May-8 | 30.19 | 31.21 | 31.57 | 27.24 |
May-9 | 31.50 | 29.71 | 32.35 | 28.81 |
May-12 | 30.62 | 30.76 | 31.36 | 29.82 |
May-13 | 30.81 | 29.31 | 30.99 | 29.29 |
Veracyte Earnings
Veracyte Earnings Report: Per Share Veracyte Earnings Q1 Q2 Q3 and Q4 last year and next year.
Veracyte Forecast Revenue Growth
Veracyte Stock Analysis: Historical quarterly revenues per share for Veracyte and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.03 per share, an increase this year of $0.27 per share, and an increase next year of $0.01 per share.
* Veracyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.